- Home
- UCAR vs PLUR Comparison
UCAR vs PLUR Comparison
Compare UCAR & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UCAR | PLUR |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5M | 36.3M |
| IPO Year | 2022 | 2001 |
Fundamental Metrics
Financial Performance| Metric | UCAR | PLUR |
|---|---|---|
| Price | $1.35 | $2.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $50.00 | $12.00 |
| AVG Volume (30 Days) | ★ 480.7K | 15.0K |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,336,000.00 |
| Revenue This Year | N/A | $97.38 |
| Revenue Next Year | N/A | $293.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 309.82 |
| 52 Week Low | $0.04 | $2.22 |
| 52 Week High | $4.98 | $5.96 |
Technical Indicators
Market Signals| Indicator | UCAR | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 46.86 | 33.53 |
| Support Level | $1.14 | $2.22 |
| Resistance Level | $1.68 | $2.60 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 22.77 | 13.73 |
Price Performance
Historical ComparisonAbout UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.